This article has Open Peer Review reports available.
The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy
- Chih-Jen Yang†1, 2, 4, 5,
- Jen-Yu Hung†2, 4,
- Ming-Ju Tsai2,
- Kuan-Li Wu2, 6,
- Ta-Chih Liu3, 4,
- Shah-Hwa Chou4, 7,
- Jui-Ying Lee7,
- Jui-Sheng Hsu4, 5Email author,
- Ming-Shyan Huang2, 4, 5 and
- Inn-Wen Chong2, 4Email author
© The Author(s). 2017
Received: 11 December 2016
Accepted: 28 February 2017
Published: 10 May 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|11 Dec 2016||Submitted||Original manuscript|
|25 Dec 2016||Reviewed||Reviewer Report - Tao Che|
|25 Dec 2016||Reviewed||Reviewer Report - Niki Karachaliou|
|10 Jan 2017||Author responded||Author comments - Chih-Jen Yang|
|Resubmission - Version 2|
|10 Jan 2017||Submitted||Manuscript version 2|
|13 Jan 2017||Reviewed||Reviewer Report - Niki Karachaliou|
|15 Jan 2017||Reviewed||Reviewer Report - Tao Che|
|24 Jan 2017||Author responded||Author comments - Chih-Jen Yang|
|Resubmission - Version 3|
|24 Jan 2017||Submitted||Manuscript version 3|
|11 Feb 2017||Author responded||Author comments - Chih-Jen Yang|
|Resubmission - Version 4|
|11 Feb 2017||Submitted||Manuscript version 4|
|28 Feb 2017||Editorially accepted|
|10 May 2017||Article published||10.1186/s40360-017-0130-0|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.